The impact of disagreement between prognostic risk scores on oncologic outcomes of metastatic renal cell carcinoma (mRCC) patients in the tyrosine-kinase inhibitor (TKI) era

• F. Janisch,
• P. Marks,
• C.P. Meyer,
• H. Yu,
• C. Fühner,
• R. Dahlem,
• M. Abufaraj,
• S.F. Shariat,
• M. Fisch,
• M. Rink

Affiliations

F. Janisch

P. Marks

C.P. Meyer

H. Yu

C. Fühner

R. Dahlem

M. Abufaraj

S.F. Shariat

M. Fisch

M. Rink